Lymph nodes & spleen, nonlymphoma

Lymph nodes-inflammatory / reactive disorders

Reactive B cell rich lymphoid proliferations that can mimic lymphoma



Last author update: 26 September 2023
Last staff update: 26 September 2023

Copyright: 2022-2024, PathologyOutlines.com, Inc.

PubMed Search: Reactive B cell rich lymphoid proliferations

Roman Segura-Rivera, M.D.
Roberto N. Miranda, M.D.
Page views in 2023: 1,208
Page views in 2024 to date: 1,048
Cite this page: Segura-Rivera R, Marques-Piubelli ML, Miranda RN. Reactive B cell rich lymphoid proliferations that can mimic lymphoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html. Accessed April 19th, 2024.
Definition / general
  • Heterogeneous group of nonneoplastic proliferations that mimic B cell lymphomas and affect lymphoid tissue in nodal or extranodal sites
Essential features
  • Heterogeneous group of nonneoplastic proliferations that mimic B cell lymphomas and affect lymphoid tissue in nodal or extranodal sites
  • 3 different main patterns
    • Nodal and extranodal follicular proliferations
    • Nodal and extranodal nodular proliferations
    • Nodal and extranodal immunoblastic proliferations
Nodal follicular / nodular proliferations
Florid follicular hyperplasia (Hematol Oncol Clin North Am 2009;23:729)
  • Increased number of widely spaced primary and secondary follicles
    • Florid cases usually involve medulla
  • Follicles show uneven size and shape
  • Hyperplastic germinal centers (GC) comprise a mixture of centroblasts and centrocytes with brisk mitoses, reactive T cells, follicular dendritic cells (FDCs) and tingible body macrophages (Ann Diagn Pathol 2020;44:151421)
    • B lymphocytes
      • Centroblasts
        • Mainly in the dark zone of GC
        • 3 - 4x size of small lymphocytes
        • Large vesicular nuclei, 1 - 3 peripheral nucleoli
      • Centrocytes
        • Mainly in the light zone of GC
        • Small to intermediate sized cells with cleaved, hyperchromatic nuclei and small or absent nucleolus
      • Both centroblasts and centrocytes are BCL6+, CD10+, LMO2+, HGAL / GCET+, OCT2+
    • T lymphocytes
      • Small and round
      • CD3+ and BCL2+
      • Subset of T helper cells (TFH): polarized CD4+, PD-1 / CD279+, BCL6+, CD10+, CXCL13+, ICOS+
    • Follicular dendritic cells (FDCs)
      • Few (usually ~1%)
      • 2 square shaped and adjacent nuclei (kissing cells) with vesicular chromatin
        • May display small nucleolus
      • Long cytoplasmic processes
      • CD21+, CD23+ or CD35+
    • Tingible body macrophages
      • Display oval or twisted vesicular nuclei
      • Abundant pale cytoplasm containing karyorrhectic nuclei
      • Impart a starry sky pattern when prominent
      • CD4+, CD68+ or CD163+
  • Well developed mantle zones
  • Distinction from germinal centers
    • Composed predominantly of small lymphocytes and IgD+
  • No or limited extension outside the capsule into perinodal soft tissue
  • Location can suggest underlying disease and additional workup is necessary to confirm the diagnosis (Pediatr Clin North Am 2002;49:1009)
    • Cervical: infectious mononucleosis
    • Posterior cervical: toxoplasmosis
    • Parotid, submaxillary, epitrochlear: HIV infection
    • Cervical and axillary: cat scratch disease, dermatopathic lymphadenitis
    • Inguinal: sexually transmitted diseases
  • Immunoarchitecture (Ann Diagn Pathol 2020;44:151421, Clin Lab Med 2021;41:433)
    • Lymphoid follicles express B cell antigens
    • Primary follicles
      • Small lymphocytes
      • BCL2+, Ki67 (usually < 10%), BCL6- and CD10-
    • Secondary follicles
      • GCs are BCL2-
        • TFH cells: subset of T cells in germinal centers are BCL2 positive and occasionally are increased
          • May mimic follicular lymphoma
        • Pediatric type follicular lymphoma (FL) is BCL2 negative
      • High proliferation Ki67
        • Polarization (centroblast rich dark zone and a centrocyte rich pale zone)
        • Low Ki67 proliferation rate within a germinal center should always be considered atypical and suspicious for follicular lymphoma
      • BCL6+ and CD10+ are restricted to GCs, minimal in interfollicular areas
  • Flow cytometry
    • Polytypic B cells; CD10+, T cell antigens-
  • Polymerase chain reaction (PCR)
    • Polyclonal immunoglobulin heavy chain gene rearrangement
    • No evidence of t(14;18)(q32;q21) or IGH::BCL2 fusion

Progressive transformation of germinal centers (PTGC) (Virchows Arch 2019;475:771)
  • Single or few large (4 - 5x normal) lymphoid follicles with mantle cells extensively indenting into GCs
  • Background lymph node exhibits reactive follicular hyperplasia (RFH)
  • Negative for rosetting by PD-1+ cells (TFH) around large B cells
  • GCs remnants rarely show tingible body macrophages
  • Morphological changes seem to proceed gradually
    • Early stages show hyperplastic GCs
    • Fusion of GCs within one single follicle (usually 2 - 3x size)
    • Inward migration of mantle zone small B cells into the germinal center
    • Later stages: dissolution of GCs results in islands or scattered centrocytes and centroblasts with follicular dendritic cells among small mantle zone B cells
  • Immunoarchitecture
    • Preserved B and T cell compartments of lymph node and prominent follicular pattern
    • Both GC and mantle zone cells express pan-B cell antigens
    • Mantle cells: BCL2+, IgD+, BCL6- and CD10-
    • Disrupted GCs: BCL6+, CD10+, BCL2- and IgD-
    • CD21, CD23 or CD35 show disruption of FDCs meshwork
    • IgG4+ plasma cells: ~40 - 50% of cases
  • Flow cytometry
    • Polytypic B cells
  • Genetic testing
    • Polyclonal IGH rearrangements

Hyaline vascular Castleman disease (HVCD)
  • Young adults (Blood 2017;129:1658)
    • Usually < 30 years old
    • Can also affect children
  • Numerous follicles in cortex and medulla of lymph node or extramedullary sites
  • Obliteration of subcapsular and interfollicular sinuses
  • ≥ 2 germinal centers in follicle (also known as twinning)
  • Follicles typically large with regressed (or involuted) germinal centers
    • Mostly composed of FDCs with few lymphocytes
    • Mantle zones prominent
    • FDCs often hyperplastic and can show dysplasia
  • Many follicles show so called lollipop features
    • Concentric rings of mantle zone lymphocytes (onion skin appearance)
    • Sclerotic blood vessels radially traversing into germinal center
  • Interfollicular or stromal component is also important (J Clin Exp Hematop 2022;62:60)
    • Increased number of high endothelial venules with hyalinized walls
    • Stromal component can predominate with only a few hyaline vascular follicles
  • Clusters of plasmacytoid dendritic cells can occur
  • Plasma cells and immunoblasts are not abundant in HVCD
    • More common and abundant in plasma cell Castleman disease (PCCD)
  • Immunohistochemistry
    • HHV8 is absent
    • Polytypic B, T cells and plasma cells
    • Increased FDCs in involuted germinal centers
      • CD21+, CD23+, CD35+ or EGFR+
    • Dysplastic FDCs often stain variably for FDC markers
  • Differential diagnosis
    • Classic Hodgkin lymphoma concurrent with Castleman disease (Virchows Arch 2020;477:437)
      • Diagnosis is established upon identification of Hodgkin Reed-Sternberg (HRS) cells with usual phenotype
    • Castleman-like follicles in infectious lymphadenopathies
      • Changes are focal and sinuses are open

Table 1. Differential diagnosis between florid follicular hyperplasia and B cell lymphomas with follicular formation
Feature Florid follicular hyperplasia Follicular lymphoma Marginal zone lymphoma Mantle cell lymphoma, mantle zone pattern
Follicles Enlarged, with prominent GCs and distinct mantle zones Variably sized surrounded by faint mantle zones Nodules with remnants of GCs surrounded by monocytoid cells Thickened mantle zones
Density Low, widely spaced Back to back Variable; may be confluent Variable
Size Uneven Uniform Variable Uniform
Borders of GC Sharp, well defined Fainted, crack artifact Blurry Sharp, well defined
Distribution Cortical predominance; florid cases involve medulla Cortex and medulla Cortex and medulla Even distribution throughout cortex and medulla
Extension to perinodal fat Absent or unusual Often present Often present Uncommon
Mantle zone Present, well developed Attenuated to absent Generally absent Expanded in mantle zone pattern
Marginal zone Can be hyperplastic Absent Expanded, may coalesce Absent
Germinal center cells Colonized by monocytoid cells Absent
Tingible body macrophages Present and common Decreased or absent Decreased or absent Variable
Polarization Present Absent Absent Variable
Cytologic features Centroblasts, centrocytes and macrophages Centroblasts and centrocytes in various proportions Monocytoid and plasmacytoid; scattered large cells Small and intermediate centrocyte-like cells; few large cells
Immunoarchitecture
BCL2 Negative in GCs Positive in germinal centers of FL grades 1 - 2; 50% in FL grade 3 Positive in neoplastic cells; GC remnants are negative Positive in mantle zones
BCL6, CD10 Positive, restricted to GCs Positive in GCs and interfollicular areas Negative, GC remnants positive Positive, restricted to GCs
Ki67 High proliferation rate; polarized in GCs Low, nonpolarized Low, nonpolarized Variable in mantle zones
CD21, CD23, CD35 FDC meshworks preserved FDC meshworks preserved Distorted FDC meshworks FDC meshworks preserved
Common positive markers BCL6, LMO2, OCT2, HGAL CD10, BCL2, BCL6, LMO2 CD43, MNDA, CD5-/+ Cyclin D1, SOX11, CD5
Common negative markers CD3, BCL2 CD5, cyclin D1 CD10, cyclin D1, SOX11 CD10-, CD23- in mantle zones
Flow cytometry Polytypic Monotypic surface Ig; CD10 positive Monotypic surface Ig; CD10 neg; CD5 neg or weak Monotypic surface Ig; CD5 positive


Table 2. Differential diagnosis between progressive transformation of germinal centers and lymphomas with large nodules
Feature Progressive transformation of germinal center Nodular predominant Hodgkin lymphoma (patterns A / B) Lymphocyte rich classic Hodgkin lymphoma, nodular variant
Follicles
Size Scattered large nodules Nodules larger than PTGC Moderately enlarged
Germinal centers Variably disrupted or involuted Absent Present within neoplastic nodules
Centrocytes and centroblasts Decreased; scattered, BCL2- Absent In residual GCs
Mantle zone cells Inward growth into GCs, BCL2+ and IgD+ Absent Expanded
Reactive follicular hyperplasia Present at background Absent or focal Absent or focal
Immunoarchitecture
T follicular helper cells rosettes (PD-1+) Absent Present May be present
IgG4+ plasma cells In 40 - 50% of cases Absent Absent
Large B cells Rare immunoblasts LP cells (popcorn cells) Present, HRS cells
Immunophenotype IgG+ CD20+, CD45+, OCT2+, EMA+/-, PAX5+ strong, IgD-/+ CD30+, CD45-, CD15+, PAX5+ dim, OCT2-, EMA-, CD20-
Nodal immunoblastic proliferations
Infectious mononucleosis (Semin Diagn Pathol 2018;35:54, Virchows Arch 2019;475:771)
  • Caused by acute Epstein-Barr virus (EBV) infection
  • Histologic changes are variable and depend on disease duration
    • Early stage: reactive follicles, with mild paracortical expansion
    • Progression: follicles sparse due to interfollicular expansion
    • Advanced stage: follicles may become effaced, with interfollicular expansion
  • Interfollicular areas with numerous immunoblasts or mixed infiltrate
    • Immunoblasts can be dispersed or abundant
    • Lymphocytes range from small to intermediate and large in size
    • Plasma cells, plasmacytoid cells and histiocytes are variably present, less frequently accompanied by eosinophils
    • Sinuses are regularly occupied by immunoblasts, monocytoid B cells and histiocytes
  • Immunoblasts can be binucleated, mimicking HRS
    • Intact nodal architecture admixed with B and T immunoblasts are indicative of a reactive process
  • Focal necrosis may be present
  • Immunohistochemistry
    • HRS-like cells are CD45+, CD15-, CD30+ (weak) admixed with B and T immunoblasts
    • EBV latency type 3 (Semin Diagn Pathol 2018;35:54)
      • EBV encoded RNA (EBER) present in numerous infected cells, ranging from small and intermediate lymphocytes to HRS-like immunoblasts
      • EBNA1+, EBNA2 variable and EBNA3+
      • LMP1+ and LMP2+
    • Most lymphocytes in the background are CD8+, TIA1+

Herpesvirus lymphadenitis (Virchows Arch 2019;475:771)
  • Uncommon complication from either primary exposure or reactivation (more common)
  • Prominent immunoblastic paracortical hyperplasia
    • Similar to infectious mononucleosis
  • Sharply circumscribed areas of necrosis and sinus histiocytosis
  • Adjacent to areas of necrosis
    • Multinucleated cells with ground glass chromatin and intranuclear viral inclusions (halo)
  • Herpes simplex virus (HSV) immunohistochemistry confirms the diagnosis

Cytomegalovirus lymphadenitis (Virchows Arch 2019;475:771)
  • Morphologic features overlapping with those described in other viral infections
  • Monocytoid B cell hyperplasia is frequent
  • Characteristic owl eye central intranuclear inclusions with a halo
  • Cells infected with cytomegalovirus (CMV) often are T cells or endothelial cells
  • Diagnosis can be established utilizing CMV immunohistochemical stain

Table 3. Differential diagnosis between nodal B cell immunoblastic proliferation and lymphomas
Feature Infectious mononucleosis Classic Hodgkin lymphoma Diffuse large B cell lymphoma, EBV+
Nodal compartment Paracortical Diffuse effacement Diffuse effacement
Neoplastic cells Not present Scattered large cells; confluent in nodular sclerosis syncytial variant Abundant large cells; diffuse pattern
Background lymphocytes
B cells Small to intermediate Small Small
T cells CD8+, small to intermediate CD4+, small CD8+, small
Monocytoid B cells hyperplasia Often present Absent Absent
Plasma cells Variably present Few Not frequent
Histiocytes Variably present Variable Variable
Eosinophils Rare Present, often abundant May be present
Necrosis Focally present Often present in nodular sclerosis subtype May be present
Immunoarchitecture
EBV latency type Type III Type II Type I
EBER Positive in most cells Positive in HRS cells Positive in large cells
LMP1 Positive, fewer small and large cells (less sensitive) Restricted to HRS cells in positive cases If positive, restricted to large neoplastic cells
EBNA2 Mostly positive Negative Negative
EBNA3 Positive Negative Negative
CD20 Positive in large cells Faint reactivity in HRS cells in ~20% of cases Positive in large cells
CD3 Positive in small lymphocytes Negative in HRS cells Negative in large cells
CD30 Positive in HRS-like cells, usually dim Positive in HRS cells, strong May be positive in neoplastic cells
CD45 Positive in most cells Negative in HRS cells Positive in neoplastic cells
CD4, PD-1, ICOS, CXCL13 Negative in immunoblasts Negative in HRS cells Negative in neoplastic cells
CD21 Present only in GCs Present only in residual GCs Absent
Diagnostic molecular testing Polyclonal B and T cells Polyclonal B and T cells Monoclonal IGH gene rearrangements
Extranodal follicular proliferations
Florid reactive lymphoid hyperplasia
  • Most cases represent reactive tertiary lymphoid tissue and may be associated either with an infectious agent, autoimmune phenomena or chronic repetitive trauma; these processes may lead to extranodal marginal zone lymphoma (Pathology 2020;52:15)
    • Stomach: Helicobacter pylori
    • Skin: Borrelia burgdorferi
    • Conjunctiva: Chlamydia psittaci
    • Cervix: Chlamydia trachomatis
    • Small intestine: Campylobacter jejuni
    • Lung: Achromobacter xylosoxidans
    • Gallbladder: extrahepatic biliary obstruction
    • Thyroid: Hashimoto thyroiditis
    • Salivary gland: Sjögren syndrome
  • Differential diagnosis with marginal zone lymphoma can be challenging in some cases
  • Most cases show lymphoid infiltrate with superficial distribution, with or without ulceration
  • Architecture varies from patchy and nodular to diffuse, with secondary follicles in most cases
    • Tends to imitate lymph nodes organization, with a B follicular and T interfollicular compartments
  • Cytologically composed by small lymphocytes and polytypic plasma cells, with variable number of granulocytes and histiocytes in the background
  • Scattered large CD30+ immunoblasts are present in the majority of cases
  • Clonal IGH rearrangement is not uncommon, although patients are free of lymphoma on follow up (Arch Pathol Lab Med 2018;142:1313)

Table 4. Differential diagnosis between cutaneous follicular hyperplasia and B cell lymphomas
Feature Reactive follicular hyperplasia Primary cutaneous follicular center lymphoma Primary cutaneous marginal zone lymphoma
Infiltrate Denser in superficial dermis, wedge shaped Denser in deep dermis, Grenz zone Vertical orientation around follicles
Follicular architecture Present, uneven shapes and size Follicular or diffuse pattern Pale nodules, some residual germinal centers
Mantle zone Present, well developed Attenuated to absent Absent
Marginal zone Generally absent Absent Expanded, may coalesce
Germinal center cells Colonized by monocytoid cells
Tingible body macrophages Present Absent Present in GC remnants
Polarization Present Absent Absent
Cytologic features Centrocytes and centroblasts Centroblasts and centrocytes Monocytoid cells, few large cells; plasma cells
Immunoarchitecture B and T compartments preserved Effaced, B cell predominant Effaced, B cell predominant
BCL2 Negative in germinal centers Negative in germinal centers Positive in neoplastic cells; GC remnants are negative
BCL6 Positive, restricted to GCs Positive in both GCs and interfollicular areas Negative, GC remnants positive
Ki67 High and polarized in GCs Low, nonpolarized Low, nonpolarized
CD21, CD23, CD35 FDC meshworks preserved FDC meshworks preserved Distorted FDC meshworks
Light chain restriction Absent May be present Present in plasmacytoid lymphocytes or mature plasma cells
Positive IgH / IgK clonality assays No Yes Yes
Extranodal immunoblastic proliferations
EBV positive mucocutaneous ulcer (Surg Pathol Clin 2023;16:213)
  • Lymphoproliferative disorder characterized by EBV+ large B cells / Reed-Sternberg-like cells (RS-like cells) cells
  • Oral mucosa is most common site, followed by skin
    • Multiple small lesions within same anatomic region can occur
  • No systemic symptoms, lymphadenopathy, hepatosplenomegaly or bone marrow involvement
  • Well circumscribed superficial ulcer with a subjacent polymorphous infiltrate
  • Deep base shows a sharp demarcation by a dense rim of small lymphocytes
  • Angioinvasion and high proliferation index may be present
  • Monoclonal IGH or TCR gene rearrangements can occur in up to a third of cases
  • Immunohistochemistry
    • HRS-like cells: CD45+, CD15- and CD30+ (usually weak)
    • Background: B and T cells
    • EBV latency type 3 (Semin Diagn Pathol 2018;35:54)
      • EBV encoded RNA (EBER) present in numerous infected cells, ranging from small and intermediate lymphocytes to HRS-like immunoblasts
      • LMP1+, EBNA2+
    • Basal rim of T cells are CD8+
Case reports
Microscopic (histologic) images

Contributed by Roberto N. Miranda, M.D. and Roman Segura-Rivera, M.D.
Reactive follicular hyperplasia

Reactive follicular hyperplasia

Polarized Ki67

Polarized Ki67

Follicular lymphoma

Follicular lymphoma

Nonpolarized Ki67

Nonpolarized Ki67

Nodal marginal zone lymphoma

Nodal marginal zone lymphoma

Monocytoid cytology

Monocytoid cytology


MCL with mantle zone pattern

Mantle cell lymphoma (MCL) with mantle zone pattern

Cyclin D1 (mantle pattern) in MCL

Cyclin D1 (mantle pattern) in MCL

Progressive transformation of germinal centers

Progressive transformation of germinal centers

CD20 in PTGC

CD20 in PTGC

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)

NLPHL

LP cells

LP cells


Rosetting CD3+ lymphocytes

Rosetting CD3+ lymphocytes

Castleman disease, hyaline vascular variant

Castleman disease, hyaline vascular variant

Germinal center in HVCD

Germinal center in HVCD

Interfollicular expansion

Interfollicular expansion

Immunoblasts

Immunoblasts

Infectious mononucleosis, EBER

Infectious mononucleosis, EBER


EBV positive diffuse large B cell lymphoma

EBV positive diffuse large B cell lymphoma

EBER positivity in EBV positive diffuse large B cell lymphoma

EBER positivity in EBV positive diffuse large B cell lymphoma

Mixed cellularity classic Hodgkin lymphoma

Mixed cellularity classic Hodgkin lymphoma (MCCHL)

EBER positivity in mixed cellularity classic Hodgkin lymphoma

EBER positivity in MCCHL

Board review style question #1

Which of the following statements is true about progressive transformation of germinal center (PTGC)?

  1. Centrocytes are increased and have a BCL2+ phenotype
  2. IgG4+ plasma cells are usually absent
  3. Reactive follicular hyperplasia is usually absent in the background
  4. Rosettes of T follicular helper (TFH) cells are usually absent
Board review style answer #1
D. Rosettes of TFH cells are usually absent. Answer B is incorrect because PTGC cases usually present with IgG4+ plasma cells in up to 50% of cases. Answers A and C are incorrect because there is a decrease of centrocytes and reactive follicular hyperplasia in the background.

Comment Here

Reference: Reactive B cell rich lymphoid proliferations that can mimic lymphoma
Board review style question #2

What latency pattern is more common in infectious mononucleosis?

  1. Type 0: EBER+, LMP1-, EBNA2-
  2. Type I: EBER+, LMP1-, EBNA2-
  3. Type II: EBER+, LMP1+, EBNA2-
  4. Type III: EBER+, LMP1+, EBNA2+
Board review style answer #2
D. Type III: EBER+, LMP1+, EBNA2+. Answers A, B and C are incorrect because the most common latency pattern in infectious mononucleosis is the pattern III, which is characterized by the positivity of EBER, LMP1 and EBNA2.

Comment Here

Reference: Reactive B cell rich lymphoid proliferations that can mimic lymphoma
Back to top
Image 01 Image 02